Massimo Florio is Professor of Public Economics at the Department of Economics, Management and Quantitative Methods at Università degli Studi di Milano. Awarded by the European Commission a Jean Monnet Chair “Ad Personam” of EU Industrial Policy, he has been the scientific coordinator of a Jean Monnet network of six universities. His main research interests are in applied welfare economics, cost-benefit analysis, industrial and regional policies, infrastructure and growth, privatization, public enterprise and socio-economic impact of research infrastructures.

August 1, 2020 | Publications, Working papers | By MG

Biomed Europa:after the coronavirus,a public infrastructure to overcomethe pharmaceutical oligopoly

Working paper CIRIEC

“As of June 30th, 2020, the global outbreak of Severe Acute Respiratory Syndrome(SARS)—associated coronavirus 2 (SARS-CoV-2)has claimed about 500,000lives, with over 10 million confirmed cases and nearly 3 billion people around the world under some form of lockdown. The COVID-19 pandemic has exposed profound weaknesses in a global health system that in the last decades relied in most countries too heavily on the pro-profit private sector for the discovery, development and distribution of new drugs.” […]

Click here to read the working paper

Massimo Florio

‐ Professor of Public Economics ‐

Biomed Europa:after the coronavirus,a public infrastructure to overcomethe pharmaceutical oligopoly

Archive